Related Experiment Video

Updated: May 10, 2026

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

WEE1 inhibition and genomic instability in cancer

Lianne E M Vriend1, Philip C De Witt Hamer, Cornelis J F Van Noorden

  • 1Neurosurgical Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands; Neuro-oncology Research Group, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands; Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Biochimica Et Biophysica Acta
|June 4, 2013
PubMed

Insights

WEE1 kinase inhibition is a promising cancer therapy, particularly for tumors with p53 mutations. Chromosomal instability may predict patient response to WEE1 inhibitors, guiding treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Genomic instability is a hallmark of cancer, regulated by cell cycle checkpoints.
  • The G2 checkpoint and WEE1 kinase are crucial for DNA damage response and are often dysregulated in cancer.
  • WEE1 kinase overexpression in cancer presents a therapeutic target.

Purpose of the Study:

  • To explore the role of WEE1 kinase inhibition as a cancer therapy.
  • To investigate the potential of chromosomal instability as a biomarker for WEE1 inhibitor efficacy.
  • To determine optimal therapeutic strategies for WEE1 inhibitors in cancer treatment.

Main Methods:

  • Review of cell cycle checkpoint functions in cancer.
  • Analysis of WEE1 kinase's role in G2 checkpoint regulation.
  • Postulation of chromosomal instability as a predictor of response to WEE1 inhibition.

Main Results:

  • WEE1 inhibition shows promise in combination with DNA-damaging agents, especially in p53-mutated cancers.
  • Monotherapy with WEE1 inhibitors has demonstrated efficacy in various cancer types, including p53 wild-type.
  • Cancer cells lacking G1 arrest often rely on G2 arrest for DNA repair.

Conclusions:

  • WEE1 kinase is a key regulator of the G2 checkpoint and a viable therapeutic target in oncology.
  • Chromosomal instability may be a critical factor in predicting tumor response to WEE1 inhibitor monotherapy.
  • Incorporating chromosomal instability assessment could refine the clinical application of WEE1 inhibitors for personalized cancer therapy.
Keywords:
CancerCell cycle checkpointChromosomal instabilityGenomic instabilityWEE1 kinasep53

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Genetic Studies of Human DNA Repair Proteins Using Yeast as a Model System14:09

Genetic Studies of Human DNA Repair Proteins Using Yeast as a Model System

Published on: March 18, 2010

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...